Editor Note: For more information about this release, please scroll to bottom.
LONDON, June 2, 2014 /PRNewswire/ --
The US markets saw a mixed sentiment on Friday, May 30, 2014, with the NASDAQ Composite closing at 4,242.62, down 0.13%, the Dow Jones Industrial Average ending the session at 16,717.17, up 0.11% and the S&P 500 edging 0.18% higher to finish the trading session at 1,923.57. The session saw a positive impact from Consumer Staples, Utilities and Telecommunication Services sectors along with a drag from Energy and Materials sectors. Investor-Edge has initiated coverage on the following equities: NPS Pharmaceuticals Inc. (NASDAQ:NPSP), Doral Financial Corp. (NYSE:DRL), Retrophin Inc. (NASDAQ:RTRX) and Papa Murphy's Holdings Inc. (NASDAQ:FRSH). Free technical research on NPSP, DRL, RTRX and FRSH can be downloaded upon signing up at:
NPS Pharmaceuticals Inc.'s stock finished Friday's session 13.41% higher at $31.13. A total of 15.36 million shares were traded, which was much above its three months average volume of 2.30 million shares. The stock moved between $27.23 and $34.50 during the session. Over the past three trading sessions and last one month, NPS Pharmaceuticals Inc.'s shares have surged 11.34% and 16.94%, respectively. Also, from the year's start the stock has gained 2.54%. The S&P 500 Health Care Sector Index mapped a gain of 0.26% during the session, and it has advanced 3.20% in the last one month. The company's shares are trading above their 50-day and 200-day moving averages. Moreover, the stock's 200-day moving average of $29.42 is greater than its 50-day moving average of $27.00. NPS Pharmaceuticals Inc.'s stock has a Relative Strength Index (RSI) of 64.50. Sign up today to read free research on NPSP at:
On Friday, Doral Financial Corp.'s stock fluctuated between $2.81 and $4.29 before ending the session 39.36% higher at $3.93. Doral Financial Corp.'s stock reported a trading volume of 5.21 million shares, above its three months average volume of 0.75 million shares. Doral Financial Corp.'s shares have rallied 50.57% in the past three trading sessions. However, over the last one month and from the beginning of 2014, the company's stock has declined 58.89% and 74.90%, respectively. The S&P 500 Financials Sector Index registered a gain of 0.22% during the session, and it has advanced 1.17% in the last one month. The stock is trading below its 50-day and 200-day moving averages; the 200-day moving average of $14.24 is above its 50-day moving average of $7.07. Moreover, shares of the company have an RSI of 44.61. Sign up today to read free research on DRL at:
Retrophin Inc.'s stock gained 13.51% on Friday, closing the day at $14.62. The stock recorded a trading volume of 3.48 million shares, above its three months average volume of 0.55 million shares. The stock oscillated between $14.56 and $16.82 during the session. Over the past three trading sessions and last one month, Retrophin Inc.'s shares have advanced 1.88% and 2.31%, respectively. Also, the stock has gone up 108.86% since the start of this year. The S&P 500 Health Care Sector Index reported a gain of 0.26% during the trading session and it has advanced 0.55% in the last three months. Additionally, the stock has an RSI of 54.95. On May 29, 2014, Retrophin Inc. announced that it has signed a binding commitment on a $40 million senior secured term loan facility, provided by Athyrium Capital Management. The lender will receive warrants to purchase an aggregate of 300,000 shares of common stock for a period of five years at an exercise price of $13.93 per share. Sign up today to read free research on RTRX at:
On Friday, shares in Papa Murphy's Holdings Inc. recorded a trading volume of 0.64 million shares. The stock ended the day at $10.95, which was 11.05% above its previous day's closing price of $9.86. Further, the company's stock vacillated between $9.90 and $11.12 during the session. Shares in Papa Murphy's Holdings Inc. have surged 12.08% in the past three trading sessions. The S&P 500 Consumer Discretionary Sector Index mapped a gain of 0.09% during the session, and the index has advanced 2.06% in the last one month. Furthermore, shares of the company have an RSI of 55.71. Sign up today to read free research on FRSH at:
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.